| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sefa Vayısoğlu, Elif Anıl Yağcıoğl. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment]. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 25. issue 3. 2016-09-06. PMID:25219694. |
a significant proportion of patients with schizophrenia receiving clozapine remain with partial response. |
2016-09-06 |
2023-08-13 |
Not clear |
| Sefa Vayısoğlu, Elif Anıl Yağcıoğl. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment]. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 25. issue 3. 2016-09-06. PMID:25219694. |
the number of controlled studies evaluating augmentation of clozapine in schizophrenia patients are highest for risperidone and lamotrigine add on treatments. |
2016-09-06 |
2023-08-13 |
Not clear |
| Kathleen M Patchan, Charles Richardson, Gopal Vyas, Deanna L Kell. The risk of suicide after clozapine discontinuation: Cause for concern. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 27. issue 4. 2016-09-06. PMID:26554366. |
clozapine is a second-generation antipsychotic that has been shown to reduce suicidal ideation and suicidal behaviors in patients with schizophrenia. |
2016-09-06 |
2023-08-13 |
Not clear |
| Jagath Pushpakumara, Piyumanthi Karunarathna, Sivagamaroobasunthari Sivathiran, Ajantha Liyanage, Jegarajah Indrakuma. Clozapine induced pancytopenia leading to severe sepsis: an unusual early complication. BMC research notes. vol 8. 2016-09-06. PMID:26674072. |
clozapine is a second generation antipsychotic used to treat resistant schizophrenia and other psychotic illnesses. |
2016-09-06 |
2023-08-13 |
Not clear |
| Pichai Ittasakul, Anthony Archer, Jennifer Kezman, Wanlop Atsariyasing, Morris B Goldma. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient. Clinical schizophrenia & related psychoses. vol 10. issue 2. 2016-09-01. PMID:27440213. |
rapid rechallenge with clozapine following pronounced myocarditis in a treatment-resistant schizophrenia patient. |
2016-09-01 |
2023-08-13 |
Not clear |
| John M Kane, Christoph U Correl. The Role of Clozapine in Treatment-Resistant Schizophrenia. JAMA psychiatry. vol 73. issue 3. 2016-08-22. PMID:26841681. |
the role of clozapine in treatment-resistant schizophrenia. |
2016-08-22 |
2023-08-13 |
Not clear |
| John Lally, Mary J Docherty, James H MacCab. Pharmacological interventions for clozapine-induced sinus tachycardia. The Cochrane database of systematic reviews. issue 6. 2016-08-17. PMID:27277334. |
clozapine is an efficacious treatment for treatment-resistant schizophrenia; however its use can be limited by side effect intolerability. |
2016-08-17 |
2023-08-13 |
Not clear |
| Stephen M Stah. Clozapine: is now the time for more clinicians to adopt this orphan? CNS spectrums. vol 19. issue 4. 2016-08-08. PMID:25267329. |
although many patients with schizophrenia fail to respond adequately to trials of 2 or more antipsychotics, utilization of clozapine for these patients remains low, despite recommendations for its use by accepted treatment guidelines. |
2016-08-08 |
2023-08-13 |
Not clear |
| Chien-Yu Chen, Hsien-Yuan Lane, Chieh-Hsin Li. Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 14. issue 3. 2016-08-04. PMID:27489377. |
our previous study has demonstrated that clozapine which is among the ps antipsychotics is beneficial for bmd when compared with pr antipsychotics in women with chronic schizophrenia. |
2016-08-04 |
2023-08-13 |
Not clear |
| Ippei Takeuchi, Manako Hanya, Junji Uno, Yuhei Amano, Keiko Fukai, Kiyoshi Fujita, Hiroyuki Kame. A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 14. issue 3. 2016-08-04. PMID:27489383. |
a questionnaire-based study of the views of schizophrenia patients and psychiatric healthcare professionals in japan about the side effects of clozapine. |
2016-08-04 |
2023-08-13 |
Not clear |
| Ippei Takeuchi, Manako Hanya, Junji Uno, Yuhei Amano, Keiko Fukai, Kiyoshi Fujita, Hiroyuki Kame. A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 14. issue 3. 2016-08-04. PMID:27489383. |
the aim of this study was to assess current practice related to the side effects of clozapine in clozapine-treated patients with schizophrenia and psychiatric healthcare professionals in japan. |
2016-08-04 |
2023-08-13 |
Not clear |
| Charles H Earnshaw, Lucy Powell, Owen Haene. Lessons Learned and Questions Raised by an Atypical Case of Clozapine-Induced Myocarditis. Case reports in psychiatry. vol 2016. 2016-08-01. PMID:27478671. |
a caucasian male in his early twenties suffering from treatment resistant schizophrenia was started on clozapine. |
2016-08-01 |
2023-08-13 |
Not clear |
| Valerie M Anderson, Meghan E McIlwain, Robert R Kydd, Bruce R Russel. Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders? Psychiatry research. vol 230. issue 3. 2016-07-26. PMID:26564550. |
fifty-one patients with schizophrenia were assigned to one of three groups dependent on their clinical history: (i) 16 people who had responded well to first-line antipsychotic medication, (ii) 20 people who were treatment-resistant but responding to clozapine monotherapy, (iii) 15 people who were ultra-treatment-resistant/clozapine-resistant but responding to antipsychotic polypharmacy. |
2016-07-26 |
2023-08-13 |
human |
| James E Hotham, Patrick J D Simpson, Rosalie S Brooman-White, Amlan Basu, Callum C Ross, Sharon A Humphreys, Fintan Larkin, Nitin Gupta, Mrigendra Da. Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital. CNS spectrums. vol 19. issue 5. 2016-07-21. PMID:24284256. |
augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a uk high-security hospital. |
2016-07-21 |
2023-08-12 |
Not clear |
| James E Hotham, Patrick J D Simpson, Rosalie S Brooman-White, Amlan Basu, Callum C Ross, Sharon A Humphreys, Fintan Larkin, Nitin Gupta, Mrigendra Da. Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital. CNS spectrums. vol 19. issue 5. 2016-07-21. PMID:24284256. |
clozapine is used in the management of treatment-resistant schizophrenia and is effective in reducing aggression; however a subgroup of patients is poorly responsive. |
2016-07-21 |
2023-08-12 |
Not clear |
| James E Hotham, Patrick J D Simpson, Rosalie S Brooman-White, Amlan Basu, Callum C Ross, Sharon A Humphreys, Fintan Larkin, Nitin Gupta, Mrigendra Da. Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital. CNS spectrums. vol 19. issue 5. 2016-07-21. PMID:24284256. |
here we present a case series of 6 schizophrenia patients, within a high-security hospital, who have a history of serious violence and who were treated with clozapine augmented with amisulpride. |
2016-07-21 |
2023-08-12 |
Not clear |
| Darcy Brown, Fintan Larkin, Samrat Sengupta, Jose L Romero-Ureclay, Callum C Ross, Nitin Gupta, Morris Vinestock, Mrigendra Da. Clozapine: an effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospital. CNS spectrums. vol 19. issue 5. 2016-07-21. PMID:24698103. |
a number of studies have demonstrated the anti-aggressive properties of clozapine in schizophrenia and its positive effect in borderline personality disorder. |
2016-07-21 |
2023-08-13 |
Not clear |
| William G Honer, Andrea A Jones, Allen E Thornton, Alasdair M Barr, Ric M Procyshyn, Fidel Vila-Rodrigue. Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 60. issue 3 Suppl 2. 2016-07-20. PMID:25886676. |
response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophrenia. |
2016-07-20 |
2023-08-13 |
Not clear |
| G Piriu, E Torac, L E Gaman, L Iosif, I C Tivig, C Delia, M Gilca, I Stoian, V Atanasi. Clozapine and risperidone influence on cortisol and estradiol levels in male patients with schizophrenia. Journal of medicine and life. vol 8. issue 4. 2016-07-18. PMID:26664488. |
clozapine and risperidone influence on cortisol and estradiol levels in male patients with schizophrenia. |
2016-07-18 |
2023-08-13 |
human |
| G Piriu, E Torac, L E Gaman, L Iosif, I C Tivig, C Delia, M Gilca, I Stoian, V Atanasi. Clozapine and risperidone influence on cortisol and estradiol levels in male patients with schizophrenia. Journal of medicine and life. vol 8. issue 4. 2016-07-18. PMID:26664488. |
we have investigated the effects of clozapine and risperidone on estradiol levels in men with schizophrenia. |
2016-07-18 |
2023-08-13 |
human |